CWM
AKRO

CIBC World Markets’s Akero Therapeutics AKRO Stock Holding History

CIBC World Markets’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$460K Sell
8,612
-7,930
-48% -$360K ﹤0.01% 914
2025
Q1 		$670K Buy
+16,542
New +$701K 0.01% 862

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CIBC World Markets's AKRO Position: Q2 2025 in Review

CIBC World Markets reduced its Akero Therapeutics (AKRO) stake by 48% in Q2 2025, selling an estimated $360K and leaving 8,612 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #914.

CIBC World Markets first reported a position in AKRO in Q1 2025 and has held it in 2 quarters since. The position peaked at $670K in Q1 2025. 257 funds tracked by Wall St. Rank hold AKRO as of Q2 2025.

  • CIBC World Markets held 8,612 shares of Akero Therapeutics worth $460K as of Q2 2025.
  • CIBC World Markets sold 7,930 Akero Therapeutics shares in Q2 2025, an estimated $360K.
  • Akero Therapeutics made up ﹤0.01% of CIBC World Markets's portfolio in Q2 2025, its #914 holding.
  • CIBC World Markets first reported a position in Akero Therapeutics in Q1 2025 and has held it in 2 quarters since.
  • CIBC World Markets's Akero Therapeutics position peaked at $670K in Q1 2025.
  • 257 funds tracked by Wall St. Rank held Akero Therapeutics as of Q2 2025.

Based on CIBC World Markets's 13F filing for Q2 2025, filed 14 Aug 2025.